Search

Jenny Harry

Dr Jenny Harry has 20 years of experience in executive management, securing global partnerships, commercialising technologies and raising capital. As chief executive and managing director of Tyrian Diagnostics (ASX:TDX), she transformed the company from an R&D business to a diagnostics company, and oversaw development of the company’s first diagnostic products through to commercialisation and early revenue generation. Her corporate experience extends to leading companies in the biotechnology and biopharmaceutical sectors with expertise in creating effective organisation structures, building high performing teams, strategic planning, and negotiating with multi-national corporations on the development and commercialisation of products. Dr Harry received a PhD in developmental biology from Macquarie University, Sydney and is a graduate of the Harvard Business School General Manager Program and the Australian Institute of Company Directors. In addition to her role as managing director at Ondek®, Dr Harry is a non-executive director on several boards including as chair of QUT Enterprise Holdings and non-executive director of Solvanix.
Bio last updated 10 Sep 2017

Access to our data for Jenny Harry is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Jenny Harry is linked to 1 organisation which is included in 1 list - Technology Companies.

To see the data you will need to .

Roles

2012
Chief Executive Officer
Year started and most recent title

Share Transactions

31/08/18
$20k Bought
16/03/18
$17k Issued
28/02/18
$13k Bought
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer